基于博来霉素诱导的A549细胞衰老探讨补阳还五汤改善特发性肺纤维化的作用机制OA
Buyang Huanwutang Ameliorates Idiopathic Pulmonary Fibrosis by Inhibiting Bleomycin-induced Senescence of A549 Cells
目的:研究补阳还五汤(BHT)含药血清对博来霉素(BLM)诱导的A549细胞衰老影响,进一步探讨BHT改善肺纤维化的潜在机制.方法:体外培养A549细胞,利用BLM构建A549细胞衰老模型,通过SD大鼠灌胃BHT后制备含药血清.研究BHT含药血清对BLM诱导的A549细胞衰老模型细胞活力的影响,将实验分为空白组,模型组,2.5%、5%、10%BHT含药血清组.研究BHT含药血清对BLM诱导的A549细胞衰老模型细胞衰老的影响,设立空白组,模型组,阳性药组(PC组,吡非尼酮,600 mg·L-1)及2.5%、5%、10%BHT含药血清组,采用β-半乳糖苷酶活性(SA-β-Gal)染色法测定衰老阳性细胞面积,流式细胞术分析细胞周期分布,实时荧光定量聚合酶链式反应(Real-time PCR)与免疫荧光(IF)检测细胞衰老分子标志物p16、p21的mRNA及蛋白表达,蛋白免疫印迹法(Western blot)检测衰老相关分泌表型(SASP)白细胞介素(IL)-1β、IL-6、基质金属蛋白酶(MMP)-3、趋化生长因子(CCL)、肿瘤坏死因子(TNF)-α及转化生长因子(TGF)-β/Smad通路TGF-β1、Smad2、磷酸化(p)-Smad2、Smad3、p-Smad3的蛋白表达.结果:经BLM诱导后,与空白组比较,模型组细胞存活率显著降低(P<0.01),SA-β-Gal染色阳性面积、细胞周期的G0/G1期比例、细胞衰老分子标志物p16与p21的mRNA及蛋白表达、SASP组分IL-1β、IL-6、TNF-α、MMP-3、CCL2和TGF-β/Smad信号通路蛋白组分TGF-β1、p-Smad2、p-Smad3的蛋白表达均明显升高(P<0.05,P<0.01).BHT含药血清干预后,与模型组比较,BHT含药血清各组细胞存活率显著升高(P<0.01),SA-β-Gal染色阳性面积、细胞周期的G0/G1期比例、细胞衰老分子标志物p16与p21的mRNA及蛋白表达、SASP组分IL-1β、IL-6、TNF-α、MMP-3、CCL2的蛋白表达明显降低(P<0.05,P<0.01),且BHT含药血清对细胞衰老的抑制作用呈现剂量依赖性,以10%BHT含药血清作用最明显,并显著抑制了TGF-β1、p-Smad2、p-Smad3的表达(P<0.01).同时,10%BHT含药血清与吡非尼酮作用效果相当,甚至对TNF-α及Smad2蛋白表达的抑制作用更优(P<0.05).结论:BHT含药血清可以抑制BLM诱导的A549细胞衰老,且作用呈现剂量依赖性特征,其机制可能与TGF-β/Smad通路有关.
Objective:To investigate the effect of the Buyang Huanwutang(BHT)-containing serum on the bleomycin-induced senescence of A549 cells and explore the potential mechanism by which BHT ameliorates pulmonary fibrosis.Methods:A549 cells were cultured in vitro and modeled for senescence through the application of bleomycin.SD rats were administrated with BHT by gavage for the preparation of BHT-containing serum,and the effect of BHT-containing serum on the viability of the cell model was studied through a cell experiment designed with the following groups:blank group,model group,2.5%,5%,and 10%BHT-containing serumgroups.The effect of BHT-containing serum on the BLM-induced senescence of A549 cells was studied by the experiment designed with blank group,model group,positive group(PC,pirfenidone,600 mg·L-1),2.5%,5%,10%BHT-containing serum groups.SA-β-Gal staining was used to reveal the area of senescence-positive cells,and flow cytometry was employed to analyze the cell cycle distribution.Real-time PCR and the immunofluorescence assay were adopted to determine the mRNA and protein levels of cell senescence markers p16 and p21.Western blot was employed to quantify the protein levels of senescence-associated secretory phenotype(SASP)molecules interleukin(IL)-1β,IL-6,matrix metalloproteinase(MMP)-3,chemokine ligand(CCL)2,tumor necrosis factor(TNF)-α,and transforming growth factor-β(TGF-β)/Smad pathway molecules TGF-β1,Smad2,phosphorylated(p)-Smad2,Smad3,and p-Smad3.Results:Compared with the blank group,the model group showed a decrease in cell survival rate(P<0.01),increases in the SA-β-Gal-positive area,the proportion of cells in G0/G,phase,the mRNA and protein levels of P16 and P21,and the protein levels of IL-1β,IL-6,TNF-α,MMP-3,CCL2,TGF-β1,p-Smad2,and p-Smad3(P<0.05,P<0.01).Compared with the model group,the BHT-containing serum at each dose increased the cell survival rate(P<0.01)and decreased the SA-β-Gal-positive area,the proportion of cells in G0/G1 phase,the mRNA and protein levels of p16 and p21,and the protein levels of IL-1β,IL-6,TNF-α,MMP-3,and CCL2(P<0.05,P<0.01).Moreover,the inhibitory effect of BHT-containing serum on cell senescence showed a dose-dependent manner,with the 10%BHT-containing serum showing the most obvious effects and inhibiting the expression of TGF-β1,p-Smad2,and p-Smad3(P<0.01).The effect of 10%BHT-containing serum was comparable to that of pirfenidone,and the serum even outperformed pirfenidone in inhibiting the expression of TNF-α and Smad2(P<0.05).Conclusion:The BHT-containing serum can inhibit BLM-induced senescence of A549 cells in a dose-dependent manner by regulating the TGF-β/Smad signaling pathway.
罗朝磊;渠景连
贵州中医药大学,贵阳 550025贵州中医药大学,贵阳 550025
医药卫生
补阳还五汤特发性肺纤维化A549细胞细胞衰老衰老相关分泌表型(SASP)
Buyang Huanwutangidiopathic pulmonary fibrosisA549 cellscell senescencesenescence-associated secretory phenotype(SASP)
《中国实验方剂学杂志》 2026 (5)
11-20,10
国家自然科学基金项目(82160892)
评论